ERYTECH Pharma S.A. Made Big Gain
Fri, Jul 30, 2021 at 05:30 PM
ERYTECH Pharma S.A. (ERYP:NASDAQ) shot up at $6.37, representing a gain of 55%. On Thu, Jul 29, 2021, ERYP:NASDAQ touched a New 2-Week Low of $4.11. The stock appeared on our News Catalysts scanner on Fri, Jul 30, 2021 at 12:05 PM in the 'BIOTECH' category. From Thu, Jul 15, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About ERYTECH Pharma S.A. (ERYP:NASDAQ)
Erytech Pharma is a biopharmaceutical company. The Company's product ERY-ASP, named GRASPA 2 in Europe and Israel, is positioned in the treatment of acute leukemia, a cancer of the blood and bone marrow.
Top 10 Gainers:
- ERYTECH Pharma S.A. (ERYP:NASDAQ), 54.99%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 38.89%
- Marin Software Incorporated (MRIN:NASDAQ), 28.17%
- Atlassian Corporation Plc (TEAM:NASDAQ), 21.86%
- iFresh Inc. (IFMK:NASDAQ), 21.62%
- RLYB (RLYB:NASDAQ), 20.57%
- SNTG (SNTG:NASDAQ), 17.27%
- Silicon Motion Technology Corporation (SIMO:NASDAQ), 16.63%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 15.37%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 14.49%